{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:05:29Z","timestamp":1725149129886},"reference-count":15,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Aesthet Surg"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/jcas.jcas_68_17","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T10:02:26Z","timestamp":1549015346000},"page":"167","source":"Crossref","is-referenced-by-count":3,"title":["Overview of medical therapies and phototherapy in vitiligo based on their pathogenetic action and the role of platelet-rich plasma"],"prefix":"10.25259","volume":"11","author":[{"given":"Kabir","family":"Sardana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0974-2077.251416-1","first-page":"257","volume-title":"Vitiligo pathogenesis and emerging treatments","author":"Rashighi","year":"2017","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0974-2077.251416-2","first-page":"107","volume-title":"The medical treatment of vitiligo: An historical review","author":"Nordlund","year":"2017","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0974-2077.251416-3","first-page":"437","volume-title":"A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo","author":"Korobko","year":"2016","journal-title":"Dermatol Ther"},{"key":"key-10.4103\/0974-2077.251416-4","first-page":"239","volume-title":"BB-UVA vs.NB-UVB in the treatment of vitiligo: A randomized controlled clinical study (single blinded)","author":"El-Mofty","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"key-10.4103\/0974-2077.251416-5","first-page":"165","volume-title":"Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5\u2019,8-trimethylpsoralen, and psoralen in vitiligo","author":"Pathak","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"key-10.4103\/0974-2077.251416-6","first-page":"9","volume-title":"Minocycline protects melanocytes against H2O2-induced cell death via JNK and p38 MAPK pathways","author":"Song","year":"2008","journal-title":"Int J Mol Med"},{"key":"key-10.4103\/0974-2077.251416-7","first-page":"1982","volume-title":"Potential advantages of simvastatin as a novel anti-vitiligo arsenal","author":"Feily","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key-10.4103\/0974-2077.251416-8","first-page":"171","volume-title":"Phototherapy and combination therapies for vitiligo","author":"Esmat","year":"2017","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0974-2077.251416-9","first-page":"42","volume-title":"Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial","author":"Lim","year":"2015","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/0974-2077.251416-10","first-page":"108","volume-title":"The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study","author":"Ibrahim","year":"2016","journal-title":"J Cosmet Dermatol"},{"key":"key-10.4103\/0974-2077.251416-11","doi-asserted-by":"crossref","unstructured":"Lim K, Shin M-K, Lee M-H. Clinical application of platelet-rich plasma in vitiligo: a pilot study. A poster presented in the Official XXIst International Pigment Cell Conference Website, Bordeaux, France, Sept 21\u201324, 2011.","DOI":"10.1111\/j.1755-148X.2011.00885.x"},{"key":"key-10.4103\/0974-2077.251416-12","first-page":"133","volume-title":"Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo","author":"K\u00f6se","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/0974-2077.251416-13","first-page":"401","volume-title":"Regression of melasma with platelet-rich plasma treatment","author":"\u00c7ay\u0131rl\u0131","year":"2014","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0974-2077.251416-14","first-page":"119; author reply 120","volume-title":"Effect of tacrolimus on vitiligo in absence of UV radiation exposure","author":"Sardana","year":"2007","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0974-2077.251416-15","first-page":"406","volume-title":"The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial","author":"El","year":"2016","journal-title":"Dermatol Ther"}],"container-title":["Journal of Cutaneous and Aesthetic Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:14:01Z","timestamp":1725088441000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcasonline.com\/overview-of-medical-therapies-and-phototherapy-in-vitiligo-based-on-their-pathogenetic-action-and-the-role-of-platelet-rich-plasma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"alternative-id":["251416"],"URL":"https:\/\/doi.org\/10.4103\/jcas.jcas_68_17","relation":{},"ISSN":["0974-2077"],"issn-type":[{"type":"print","value":"0974-2077"}],"subject":[],"published":{"date-parts":[[2018]]}}}